Andrea Nervegna

Assoc. Director, Commercial Lead EMEA - Brensocatib at Insmed

Andrea Nervegna, MBA has a diverse work experience in the pharmaceutical industry, with a focus on marketing and brand management. Andrea is currently working at Insmed Incorporated as the Associate Director, Commercial Lead EMEA for Brensocatib, a first-in-class DPP1-inhibitor. In this role, they are responsible for shaping the go-to-market strategy and new product planning for the Region.

Prior to their current role, Andrea worked at Mundipharma as the Marketing Manager for Respiratory & Pain in Italy. Andrea was promoted to this role as part of a change management project to create Mundi 2.0. Andrea also served as the Brand Leader for Respiratory in Italy, where they successfully revamped the sell-out growth rate for ICS/LABA Flutiform and led pre-launch activities for Flutiform K-Haler.

Andrea also has experience working at Novartis as the Brand Leader for Entresto in Italy, and at MENARINI Group as the Global Brand Manager for Respiratory. At MENARINI, they led the global roll-out of LAMA/LABA Brimica Genuair launch and launched the ICS/LABA Gibiter Easyhaler in Europe. Andrea also supported marketing activities in MENA and launched the antiH1 Bilastine in APAC and Kenya.

Additionally, Andrea has previous experience as a Junior Product Manager in the Diagnostics division at MENARINI, where they worked in cytology and digital pathology.

Overall, Andrea Nervegna's work experience demonstrates their expertise in marketing, brand management, and successful product launches within the pharmaceutical industry.

Andrea Nervegna, MBA has a strong educational background in biotechnology and business administration. In 2008, they started their academic journey at Abertay University, where they pursued a Bachelor of Science (Honors) in Medical Biotechnology. This program lasted until 2009, allowing their to deepen their understanding of the field.

Building on their undergraduate studies, Andrea continued their education at Abertay University, where they enrolled in their MBA Biotechnology program in 2009. Andrea successfully completed this degree in 2010, further enhancing their knowledge and expertise in the field of business administration and management, with a specific focus on biotechnology.

In addition to their formal education, Andrea has also sought out additional certifications to supplement their knowledge and skills. In July 2019, they completed a certification program titled "Successfully Managing People" at the Management Centre Europe (MCE), further honing their abilities in managing and leading others. More recently, in July 2020, they obtained a certification in "Digital Marketing Strategies" from the Kellogg Executive Education, demonstrating their commitment to keeping up-to-date with the latest trends and strategies in the digital marketing landscape.

Overall, Andrea Nervegna, MBA has a well-rounded educational background in biotechnology, business administration, and digital marketing strategies.

Links

Previous companies

Novartis logo
Mundipharma logo

Timeline

  • Assoc. Director, Commercial Lead EMEA - Brensocatib

    July, 2022 - present

  • Assoc Director Manager Marketing EMEA

    April, 2020

View in org chart